NVDX3

· Novadip Biosciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NVDX3, covering 2024-09-05 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures. [Phase 1, Phase 2]